NEXGEL (NASDAQ:NXGL) Issues Earnings Results

NEXGEL (NASDAQ:NXGLGet Free Report) released its quarterly earnings results on Monday. The company reported ($0.08) EPS for the quarter, Zacks reports. NEXGEL had a negative net margin of 52.60% and a negative return on equity of 71.19%.

NEXGEL Stock Up 14.4 %

NXGL traded up $0.39 during trading on Monday, hitting $3.09. The stock had a trading volume of 74,673 shares, compared to its average volume of 64,378. The stock has a 50 day simple moving average of $3.24 and a two-hundred day simple moving average of $3.27. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.93 and a current ratio of 1.51. NEXGEL has a twelve month low of $1.84 and a twelve month high of $5.10. The company has a market capitalization of $20.98 million, a PE ratio of -5.33 and a beta of 0.62.

About NEXGEL

(Get Free Report)

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.

Read More

Earnings History for NEXGEL (NASDAQ:NXGL)

Receive News & Ratings for NEXGEL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NEXGEL and related companies with MarketBeat.com's FREE daily email newsletter.